ObjectivesThe objective of this study was to identify the mechanisms of cefotaxime resistance (CTX-R) in 1226 Escherichia coli from 4581 environmental samples collected on 53 dairy farms over a 2-year period in South West England and to characterise a blaCTX-M-32-producing plasmid, pMOO-32, found to be widely distributed.MethodsCTX-R isolates were identified using MIC breakpoint agar plates. β-lactamase genes of interest (GOIs) were detected by PCR. WGS was performed and analysed using the Center for Genomic Epidemiology platform. A plasmid-specific multiplex PCR was designed to indicate the presence of plasmid pMOO-32.ResultsAmongst 1226 CTX-R isolates, PCR identified blaCTX-M group 1 (549 isolates), blaCTX-M group 9 (100 isolates), blaCMY (12 isolates), blaDHA (1 isolate) and no GOI (566 isolates). WGS analysis of 184 representative isolates identified blaCTX-M (131 isolates; encoding CTX-M-1, -14, -15, -32 and the novel variant, CTX-M-214), blaCMY-2 (6 isolates), blaDHA-1 (one isolate) and presumed AmpC-hyperproduction in 46 isolates that were PCR negative for GOIs. A highly conserved plasmid was identified in 73 isolates, representing 27 E. coli STs. This ∼220 kb IncHI2 plasmid carrying blaCTX-M-32 was designated pMOO-32, was found to be stable in cattle and human transconjugant E. coli even in the absence of selective pressure, and was found by multiplex PCR to be present on 26/53 study farms.Conclusionsβ-lactamases capable of conferring resistance to third generation cephalosporins were evident on 47/53 farms within this study. This was largely because of the widespread dissemination of an IncHI2 plasmid carrying blaCTX-M-32.